Skip to Content
Merck
  • Controlled co-release of doxorubicin and reactive oxygen species for synergistic therapy by NIR remote-triggered nanoimpellers.

Controlled co-release of doxorubicin and reactive oxygen species for synergistic therapy by NIR remote-triggered nanoimpellers.

Materials science & engineering. C, Materials for biological applications (2017-03-04)
Beibei Hou, Weitao Yang, Chunhong Dong, Bin Zheng, Ying Zhang, Jing Wu, Hanjie Wang, Jin Chang
ABSTRACT

How to encapsulate and transport the payload of multiple therapeutic compounds avoiding premature leakage, and simultaneously co-release them rapidly at specific lesions still remains the major concern in clinic. Herein, we designed the UCN@mSiO

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
8-Bromooctanoic acid, 97%
Sigma-Aldrich
Triethoxysilane, 95%
Sigma-Aldrich
Oleic acid, technical grade, 90%
Sigma-Aldrich
1-Octadecene, technical grade, 90%